This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Trypanosoma cruzis B13 Antigen, N-His
Product Overview
BioVenic's Recombinant Trypanosoma cruzis B13 Antigen, N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 22.5 kDa. The purity is>95% (SDS-PAGE).
Specifications
Target Information
Trypanosoma cruzis B13 antigen is an immunodominant protein found on the surface of trypomastigotes, which is the infective form of the parasite. It exhibits cross-reactivity with the human cardiac myosin heavy chain, suggesting a role in the development of pathology in Chagas disease. The B13 antigen is used in serodiagnosis and is considered a potential target for vaccine development due to its immunogenicity and involvement in host-parasite interactions.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.